Skip to main content
. 2018 Feb 20;109(4):1263–1275. doi: 10.1111/cas.13515

Figure 3.

Figure 3

(A) Expression of SNCA in Group 4 medulloblastomas on the RNA level was significantly higher than each of the other three subgroups (P < .0001). (B) Significant difference was found in the proportions of α‐synuclein (α‐syn) immunoreactivity in Group 4 compared with WNT and SHH groups. *P < .05. Protein expression level in Group 4 (means, 27.62% ± 5.932%; n = 21) was higher than that of Group 3 (means, 19.44% ± 6.641%; n = 18), although no statistical significance was identified (P = .3632). (C) Expression of SNCA on RNA from NanoString assay and protein levels from immunohistochemistry staining showed significant correlation (P < .0001, R 2 = .3256)